LONDON--(BUSINESS WIRE)--Technavio has been monitoring the contract development and manufacturing organization (CDMO) outsourcing market and it is poised to grow by USD 44.17 billion during 2020-2024, ...

Company demonstrates commercial-scale production of its Toll-like Receptor 5 (TLR5) agonist for Acute Radiation Syndrome (ARS ...

WUXI, China, Jan. 12, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced that two of its manufacturing ...

Minaris and Genetix Biotherapeutics have expanded their manufacturing partnership to increase commercial-scale production of ...

The newly committed suite is the first of four manufacturing suites ProMed is constructing at Niagara Lane to support growing demand for manufacture of ophthalmic implants and other sustained-release ...

Les Mintzmyer is a Sr. Biologics Manufacturing Consultant at Design Space InPharmatics. Today, Les joins the show to share his experience as a leader in the field of bio-pharmaceutical manufacturing.

Codexis Inc. and Axolabs have entered into an agreement under which Axolabs will evaluate Codexis’ ECO Synthesis ...

Dublin, April 29, 2020 (GLOBE NEWSWIRE) -- The "Pharmaceutical Contract Development And Manufacturing Organization (CMO) Global Market Report 2020-30: Covid 19 Impact and Recovery" report has been ...

The global market for contract manufacturing of medical devices is estimated to grow from $96.4 billion in 2025 to reach $155.2 billion by 2030, at a compound annual growth rate (CAGR) of 10% from ...

With more sophisticated therapeutics comes larger and more complex data sets. The complexity is heightened with the advancements in personalized medicine as it introduces new data points at apheresis ...